Does OMALIZUMAB Cause Injection site erythema? 457 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 457 reports of Injection site erythema have been filed in association with OMALIZUMAB (Omalizumab-igec). This represents 0.7% of all adverse event reports for OMALIZUMAB.
457
Reports of Injection site erythema with OMALIZUMAB
0.7%
of all OMALIZUMAB reports
4
Deaths
115
Hospitalizations
How Dangerous Is Injection site erythema From OMALIZUMAB?
Of the 457 reports, 4 (0.9%) resulted in death, 115 (25.2%) required hospitalization, and 20 (4.4%) were considered life-threatening.
Is Injection site erythema Listed in the Official Label?
Yes, Injection site erythema is listed as a known adverse reaction in the official FDA drug label for OMALIZUMAB.
What Other Side Effects Does OMALIZUMAB Cause?
No adverse event (9,736)
Asthma (9,354)
Urticaria (9,231)
Off label use (9,199)
Dyspnoea (8,323)
Drug ineffective (6,747)
Cough (5,926)
Pruritus (5,224)
Fatigue (5,053)
Malaise (4,820)
What Other Drugs Cause Injection site erythema?
ETANERCEPT (17,736)
DUPILUMAB (8,818)
ADALIMUMAB (8,563)
TIRZEPATIDE (3,844)
TERIPARATIDE (3,453)
GLATIRAMER (2,560)
IXEKIZUMAB (2,144)
ENBREL (1,879)
EVOLOCUMAB (1,754)
HUMIRA (1,654)
Which OMALIZUMAB Alternatives Have Lower Injection site erythema Risk?
OMALIZUMAB vs OMAVELOXOLONE
OMALIZUMAB vs OMBITASVIR
OMALIZUMAB vs OMBITASVIR\PARITAPREVIR\RITONAVIR
OMALIZUMAB vs OMEGA-3-ACID ETHYL ESTERS
OMALIZUMAB vs OMEGA-3-CARBOXYLIC ACIDS